Introduction
============

Health disparities refer to differences in the disease distribution and/or health outcomes across racial and ethnic groups. In the United States, health disparities in African Americans are found in life expectancy, death rates, and health measures ([@ref-28]). In addition to social determinants such as socio-economical status, health care access and cultural practices, human genetic variations play a significant role in health disparities. Genetic variations at different frequencies among populations can lead to differences in disease susceptibility. Studies on genetic variations and disease association are greatly advanced by the completion of the International HapMap Project and new genome sequencing techniques ([@ref-38]).

Genome-wide association studies (GWAS) are currently an effective approach to identify disease-associated genetic variations ([@ref-13]; [@ref-45]). Although GWAS have revealed many disease-associated single nucleotide polymorphisms (SNPs), GWAS are often limited to individual genetic variations and often do not address complex gene interactions. Moreover, associated SNPs are often located in haplotype blocks that contain more than one gene. To address these limitations, human gene networks have been used to improve GWAS detection of genes associated with complex diseases, such as the comorbidity analysis ([@ref-39]), an improved guilt-by-association method ([@ref-3]; [@ref-16]), and a distance-based scoring method using seeded diseases genes ([@ref-21]).

Copy number variations (CNVs) are duplications or deletions of genomic segments that can contain one or more genes ([@ref-24]). CNVs have been associated with complex diseases such as autism ([@ref-10]; [@ref-11]). Computational tools and methods, such as the CNV annotator ([@ref-50]) and NETBAG ([@ref-10]), have been developed to address the potential roles of CNVs in human diseases. Recently, it was reported that CNVs can occur at different frequencies between African Americans and Caucasians ([@ref-25]), and naturally the question about the potential roles of CNVs in health disparity is raised.

Here, we aim to investigate the clustering of pathogenic genes and genes in CNVs with different population frequencies in two human gene/protein networks, in order to better understand health disparities between African Americans and Caucasians. The current human gene/protein networks contain thousands of interacting molecules ([@ref-2]; [@ref-43]). We will partition gene networks into clusters and use these clusters to predict potential diseases associated with population-specific CNVs, based on the rationale that interacting genes often share similar functions ([@ref-33]).

Materials and Methods
=====================

Our overall work flow is shown in [Fig. 1](#fig-1){ref-type="fig"}. To identify potential diseases associated with CNVs, our basic idea is to identify gene interaction clusters that involve genes in population-specific CNVs. The diseases associated with a CNV-gene's interacting genes are potential diseases associated with this CNV. Specifically, we first obtained two human gene/protein networks and partitioned them into gene clusters. We then performed statistical tests on each cluster to estimate its significances in containing pathogenic genes and genes in population-specific CNVs. Finally, we ranked gene clusters based on false discovery rates (FDRs). High-ranked clusters were enriched both for pathogenic genes and for genes in CNVs with differential frequencies between African-Americans and Caucasians. These clusters were then searched for enriched Gene Ontology (GO) terms and related disease phenotypes.

![Overview of our approach to identify CNVs associated with health disparities.](peerj-03-677-g001){#fig-1}

Network clustering
------------------

We obtained two human gene/protein networks, one from Human Protein Reference Database (HPRD) ([@ref-26]; [@ref-31]; [@ref-35]) and another from MultiNet ([@ref-15]). The HPRD network (referred to as HPRDNet) contains only physical protein--protein interactions (PPIs), whereas MultiNet is a unified network including PPI, phosphorylation, metabolic, signaling, genetic and regulatory networks. These two networks share 8,468 genes (89.6% of HPRDNet and 58.6% of MultiNet) but only 8,769 interactions (23.8% of HPRDNet and 8% of MultiNet). These two networks were both partitioned into gene clusters using the Markov Cluster (MCL) Algorithm ([@ref-42]). Clustering was done with the inflation parameter I ranging from 1.1 to 2.0 with a step of 0.1. Descriptive statistics of the two networks and their clustering results are summarized in [Table S1](#supp-1){ref-type="supplementary-material"}.

Mapping of CNVs and SNPs
------------------------

CNV coordinates were obtained from a CNV map in African Americans and Caucasians ([@ref-25]). There are three types of CNVs in this map: (1) CNVs only occurred in African Americans; (2) CNVs only occurred in Caucasians; and (3) CNVs occurred in both African Americans and Caucasians. To simplify the analysis, we further partitioned the last type: CNVs that occurred more than 50% in African Americans or in Caucasians were combined with the first and second types of CNVs, respectively. This repartition resulted in two modified CNV sets with differential population frequencies. The coordinates of these CNVs were then searched in the UCSC Genome Database ([@ref-14]) through its MySQL API to obtain the corresponding gene sets. For simplicity, CNVs that occur more frequently in African Americans were called African-American CNVs or CNV_AA; CNVs that occur more frequently in Caucasians were called Caucasian CNVs or CNV\_ CA.

Disease-associated SNPs were retrieved from a file, OmimVarLocusIdSNP.bcp, from the FTP site of Single Nucleotide Polymorphism Database (dbSNP) ([@ref-40]). Coordinates of these SNPs were then queried against the MySQL API of the UCSC Genome Database to identify genes in which those SNPs are located. This identified gene set was termed as pathogenic genes. Details of gene mapping results are shown in [Table S2](#supp-2){ref-type="supplementary-material"}.

Cluster analyses
----------------

Clusters were obtained from both HPRDNet and MultiNet using MCL with a range of ten inflation parameters. For each cluster, contingency tables were constructed using the numbers of pathogenic genes and CNVs related genes ([Tables 1(A) and 1(B)](#table-1){ref-type="table"}). Right-tailed Fisher's exact tests were applied to these contingency tables to calculate enrichment significance of pathogenic genes, and CNV\_ AA or CNV\_ CA genes, respectively. Based on obtained *p*-values, false discovery rates (FDRs) were calculated using the Robust FDR Routine ([@ref-34]). Fisher's exact tests and Robust FDR Routine were both performed in the R statistical environment ([@ref-37]). Ranking was applied to clusters with *p*-value \<0.10 and FDR \<0.20 in both enrichment tests for pathogenic genes and population-preferred CNVs genes. Assuming both enrichment tests are independent, the FDR values were multiplied to jointly rank the network clusters. The same cluster analysis procedure was applied to clustering results with different MCL inflation parameters.
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###### (A) Contingency table for Fisher's exact test on pathogenic genes. (B) Contingency table for Fisher's exact test on CNV genes.
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  \(A\)                                                             
  ----------------------------- ----------- ----------------------- -----------
  **Genes in this cluster**     *q*         *m* − *q*               *m*
  **Genes in other clusters**   *Q* − *q*   *N* − *Q* − *m* + *q*   *N* − *m*
  **Total**                     *Q*         *N* − *Q*               *N*

  \(B\)                                                             
  ----------------------------- ----------- ----------------------- -----------
  **Genes in this cluster**     *s*         *m* − *s*               *m*
  **Genes in other clusters**   *S* − *s*   *N* − *S* − *m* + *s*   *N* − *m*
  **Total**                     *S*         *N* − *S*               *N*

**Notes.**

For each cluster, contingency tables were constructed for right-tailed Fisher's exact Tests. (A) is for pathogenic significance test, and (B) is for tests of enrichment significance of CNV genes (CNV_AA or CNV_CA genes). *Q* and *q* are the number of pathogenic genes in the whole networks and that in current cluster, respectively. *N* and *m* are the number of genes in whole networks and that in current cluster, respectively. *S* and *s* are the number of CNV_AA or CNV_CA genes in the whole networks and that in current cluster, respectively.

For clarity, we focused our functional analyses on clusters that were consistently ranked at the first place with different MCL inflation parameter values.

Biological significance analyses
--------------------------------

Biological relevance of selected network clusters were analyzed by GOrilla ([@ref-9]) to search for enriched gene ontology (GO) terms. In GOrilla search, genes in the selected clusters were target genes, and all genes in the network were treated as background genes. To investigate the possible links of population-specific CNVs to heath disparities, we first identified significantly enriched GO terms that are associated with CNV\_ AA or CNV\_ CA genes. We then focused on the pathogenic genes related to the enriched GO terms, and examined their associated disease phenotypes in OMIM database ([@ref-30]).

Results and Discussions
=======================

Top-ranked network clusters
---------------------------

We performed cluster analyses with ten MCL inflation parameter values for both HPRDNet and MultiNet ([Table S1](#supp-1){ref-type="supplementary-material"}), and scored the resulted clusters for their potential roles in CNV related health disparities ([Table S3](#supp-3){ref-type="supplementary-material"}). For clarity, we focused on clusters that are consistently top-ranked with different MCL inflation parameters. The graph representations of selected clusters are shown in [Fig. 2](#fig-2){ref-type="fig"}.

![Graph representations of selected clusters for biological significance analysis.\
Each rounded rectangle represents a gene and each gray line represents a gene--gene interaction. Black rounded rectangles represent non-pathogenic genes and orange rounded rectangles represent pathogenic genes. Genes labeled with red or blue ovals are located in African American CNVs or in Caucasian CNVs. Genes with green lines share the same GO terms. In each cluster, different line types represent the enrichment of different GO terms. Line types shown in different clusters refer to the enrichment of different GO terms.](peerj-03-677-g002){#fig-2}

We found four similar clusters, (AA1, AA2, and AA3 in HPRDNet and AA4 in Multinet), that are enriched both for pathogenic genes and for genes located in African-American CNVs ([Table 2](#table-2){ref-type="table"}). In HPRDNet, cluster AA1, AA2 and AA3 together were ranked at first place five times; and cluster AA4 were ranked five times in Multinet ([Table S3](#supp-3){ref-type="supplementary-material"}). Cluster AA1 contains 11 genes, within which eight are pathogenic genes ([Fig. 2A](#fig-2){ref-type="fig"}). Cluster AA2 and AA3 contain one and two more genes than cluster AA1, respectively ([Fig. S1](#supp-4){ref-type="supplementary-material"}). In MultiNet, cluster AA4 contains five genes and can be considered as a sub-cluster of cluster AA1, AA2 and AA3 ([Fig. 2B](#fig-2){ref-type="fig"}). In these four clusters, gene *HSPB1* is mainly duplicated in African Americans ([Tables 2](#table-2){ref-type="table"} and [3](#table-3){ref-type="table"}). Based on GO enrichment tests, this family of clusters was found to be involved in visual perception and eye development. Since cluster AA1, AA2 and AA3 were selected from the same network and are highly similar to each other, only cluster AA1 and AA4 will be discussed further for their potential roles in health disparities.
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###### Cluster analysis results for HPRDNet and MultiNet.
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  --------------------------------------------------------------------------------
  Network        Cluster name   CNV\_ AA   CNV\_ CA   Pathogenic\   Cluster size
                                                      gene number   
  -------------- -------------- ---------- ---------- ------------- --------------
  **HPRDNet**    AA1            *HSPB1*    --         8             11

                 AA2            *HSPB1*    --         8             12

                 AA3            *HSPB1*    --         8             13

                 CA1            --         *ATP2A1*   4             5

  **MultiNet**   AA4            *HSPB1*    --         5             5

                 CA1            --         *ATP2A1*   4             5
  --------------------------------------------------------------------------------

**Notes.**

Selected clusters were listed. CNV\_ AA and CNV\_ CA are CNV-related genes.
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###### Detected genes with potential roles in health disparity and their located CNVs.
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  Gene           Chr   Gene coordinates         CNV region               CNV type      CNV occurrence preference
  -------------- ----- ------------------------ ------------------------ ------------- --------------------------------------------
  ***HSPB1***    7     75,931,861--75,933,614   75,867,431--76,481,102   Duplication   Only in African American
                                                75,929,740--76,481,102   Duplication   Only in African American
                                                75,929,740--76,568,388   Duplication   More in African American than in Caucasian
  ***ATP2A1***   16    28,889,726--28,915,830   28,306,730--28,936,772   Duplication   Only in Caucasian

**Notes.**

Chr represents chromosomes. CNV Regions are regions of CNVs identified in more than a single individual; all CNVs listed have a type of Duplication, referring to one copy increase. CNV Regions and Types are from the CNV map ([@ref-25]). CNV Occurrence preference describes in which population those CNVs have higher occurrence frequency.

In both HPRDNet and MultiNet, the same cluster, named as CA1, was identified to be enriched with both pathogenic genes and genes located in Caucasian CNVs ([Table 2](#table-2){ref-type="table"}). Cluster CA1 was ranked at first place four times in HPRDNet and seven times in MultiNet ([Table S3](#supp-3){ref-type="supplementary-material"}). This cluster contains five genes, and four of them are associated with diseases ([Fig. 2C](#fig-2){ref-type="fig"}). The GO term enrichment tests suggested that cluster CA1 was involved in calcium ion transportation and muscle contraction regulation. Cluster CA1 contains gene *ATP2A1* that is duplicated only in Caucasians ([Table 3](#table-3){ref-type="table"}).

Duplication of *HSPB1* and health disparities in African Americans
------------------------------------------------------------------

Gene *HSPB1* is located in genomic duplication regions occurring more frequently in African Americans ([Table 3](#table-3){ref-type="table"}), and is found in the cluster family of AA1, AA2, AA3, and AA4 ([Table 2](#table-2){ref-type="table"}). For cluster AA1, only one GO molecular function term related to gene *HSPB1* is significantly enriched (Cluster AA1 in [Table 4](#table-4){ref-type="table"}). For cluster AA4, in addition to the same enriched GO molecular functions term, three GO biological process terms and one GO cellular component term are found significantly enriched (Cluster AA4 in [Table 4](#table-4){ref-type="table"}). In the genes with the enriched GO terms, four of them are known to be associated with diseases (Cluster AA1/AA4 in [Table 5](#table-5){ref-type="table"}). Among these four genes, three of them are implicated in health disparities of African Americans. Specifically, gene *CRYAB* is related to dilated cardiomyopathy and myofibrillar myopathy. African Americans were found at higher risk for idiopathic dilated cardiomyopathy compared with Caucasian, and this could not be explained by income, education, alcohol use, smoking, or history of some other diseases ([@ref-7]). Moreover, gene *CRYAA*, *CRYAB* and *CRYBB2* are all related to various types of cataract. It was reported that age-specific blindness prevalence was higher for African Americans compared with Caucasian, and cataract accounts for 36.8% of all blindness in African American, but for only 8.7% in Caucasian ([@ref-6]).
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###### Enriched GO terms with CNV-genes in the identified network clusters.
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  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Clusters                               Involved genes                   GO domain            GO ID        GO term
  -------------------------------------- -------------------------------- -------------------- ------------ ------------------------------------------------------------------------
  AA1                                    *HSPB1, CRYAA, CRYAB,CRYBB2*,\   Molecular function   GO:0042802   Identical protein binding
                                         *CRYBA1, CRYBA2*                                                   

  AA4                                    *HSPB1, CRYAA, CRYAB*            Biological process   GO:0043086   Negative regulation of catalytic activity

                                                                          Biological process   GO:0043066   Negative regulation of apoptotic process

                                                                          Biological process   GO:0043069   Negative regulation of programmed cell death

                                         *HSPB1, CRYAA, CRYAB, CRYBB2*    Molecular function   GO:0042802   Identical protein binding

                                         *HSPB1, CRYAB*                   Cellular component   GO:0030018   Z disc

  CA1[^a^](#table-4fn2){ref-type="fn"}   *ATP2A1, ATP2A2, PLN, SLN*       Biological process   GO:0090257   Regulation of muscle system process

                                                                          Biological process   GO:0006816   Calcium ion transport

                                                                          Cellular component   GO:0033017   Sarcoplasmic reticulum membrane

                                         *ATP2A1, ATP2A2, PLN*            Biological process   GO:0003012   Muscle system process

                                                                          Biological process   GO:0006874   Cellular calcium ion homeostasis

                                                                          Cellular component   GO:1902495   Transmembrane transporter complex

                                         *ATP2A1, ATP2A2, SLN*            Cellular component   GO:0016529   Sarcoplasmic reticulum

                                         *ATP2A1, ATP2A2*                 Biological process   GO:0032470   Positive regulation of endoplasmic reticulum calcium ion concentration

                                                                          Cellular component   GO:0031095   Platelet dense tubular network membrane
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes.**

Biological relevance of network clusters was analyzed by GOrilla ([@ref-9]) to search for enriched gene ontology (GO) terms. Genes in the selected clusters were used as target genes, and all genes in the networks were treated as background genes. Three types of GO terms were analyzed: biological process, molecular function and cellular component. The default *p*-value threshold (1 × 10^−3^) was used. In the results, enriched GO terms that are associated with CNV\_ AA gene *HSPB1* and CNV\_ CA gene *ATP2A1* were selected and listed in the table.

When multiple enriched GO terms show similar meanings, we only presented the most general terms.

How could *HSPB1* duplication contribute to health disparities? Based on the direct interaction between *HSPB1* and *CRYAB* and the fact that both genes are expressed in Z-disc ([Table 4](#table-4){ref-type="table"}), it is plausible that *HSPB1* may play an unknown role in cardiomyopathy. Alternatively, *HSPB1* might be involved in cataract, because *HSPB1*, *CRYAA* and *CRYAB* interact with each other and all can negatively regulate the apoptotic process ([Table 4](#table-4){ref-type="table"}). Studies suggested that lens epithelial cell apoptosis may be a common cellular basis for initiation of non-congenital cataract formation ([@ref-18]), and inhibition of epithelial cell apoptosis may be one possible mechanism that inhibits cataract development ([@ref-27]). Our results here argue for further experimental studies to test the possible role of *HSPB1* CNVs in cardiomyopathy or cataract/blindness in African Americans.

Duplication of *ATP2A1* and cardiomyopathy
------------------------------------------

Gene *ATP2A1* in cluster CA1 is located in a genomic duplication region that occurs only in Caucasians ([Table 3](#table-3){ref-type="table"}). We found that four genes in cluster CA1 are enriched with various GO terms that involve *ATP2A1* (Cluster CA1 in [Table 4](#table-4){ref-type="table"}), and three of those four genes are related to diseases when they are mutated (Cluster CA1 in [Table 5](#table-5){ref-type="table"}).
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###### Associated diseases of genes with enriched GO terms.
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  Cluster           Gene       Associated Disease
  ----------------- ---------- ------------------------------------------------------------------
  **AA1 and AA4**   *HSPB1*    Axonal Charcot-Marie-Tooth disease type 2F
                               Distal hereditary motor neuronopathy type 2B
                    *CRYAA*    Multiple types of cataract 9
                    *CRYAB*    Multiple types of cataract 16
                               Dilated cardiomyopathy-1II
                               Myofibrillar myopathy-2
                               *CRYAB*-related fatal infantile hypertonic myofibrillar myopathy
                    *CRYBB2*   Multiple types of Cataract 3
  **CA1**           *ATP2A1*   Brody myopathy
                    *ATP2A2*   Acrokeratosis verruciformis
                               Darier disease
                    *PLN*      Dilated cardiomyopathy-1P
                               Familial hypertrophic cardiomyopathy-18

**Notes.**

Only GO terms that contain CNV-genes are studied due to our focus on the role of CNV-genes in health disparity.

How would *ATP2A1* influence health disparities? Among the diseases related to the pathogenic genes in cluster CA1, idiopathic dilated cardiomyopathy occurs less often in Caucasians than in African Americans ([@ref-7]). Based on the fact that *ATP2A1* interacts directly with *PLN*, and that they are both involved in the same biological processes and exist in the same cellular component ([Table 4](#table-4){ref-type="table"}), it is plausible to suggest that duplication of *ATP2A1* may lead to the health disparity in idiopathic dilated cardiomyopathy. One possibility is that higher copies of *ATP2A1* may offer some benefits to Caucasians. Studies have shown that increased activity of sarco/endoplasmic reticulum Ca^2+^-ATPase 1 (SERCA1), which is encoded by *ATP2A1*, can partially rescue the heart from ⋅OH-induced injury ([@ref-12]), and protect the heart from ischemia-reperfusion (I/R) injury ([@ref-41]). Another possibility is that higher copies of *ATP2A1* only lead to moderate risk of cardiomyopathy in Caucasians, and this moderate effect is overshadowed by other genetics factors not covered by our CNV dataset.

Remarks, limitations, and future directions
-------------------------------------------

Although genetic factors play a crucial role in health disparities, only a few association studies have been reported in health disparities in common complex diseases, such as breast cancer ([@ref-23]), prostate cancer ([@ref-4]; [@ref-5]; [@ref-49]), type 2 diabetes ([@ref-29]) and vascular diseases ([@ref-47]).

Our study here is closely related to network-based meta-analyses of GWAS results ([@ref-1]; [@ref-17]). One important aim of network-based meta-analysis of GWAS data is to distinguish the bona fide causal gene from other genes in the same haplotype block associated with the significant SNP. Likewise, our network approach aims to predict a potential causal gene from a population-specific CNV that can be associated with pathogenic genes.

Noticeably, our method does not require network permutations, whereas many existing methods of network/pathway based meta-analyses of GWAS data do. This difference is because we first partitioned the network into clusters and then performed association tests. In comparison, many network based GWAS meta-analysis methods use traversal distances to seed genes to evaluate candidate genes. This kind of traversal distance based method generally prohibits pre-partition of network into clusters and require network permutations for estimation of *p*-values. It can be seen that our cluster-based method naturally accommodates multiple candidate genes in the association analysis, whereas traversal distance in a network is by definition often limited to single candidate gene evaluation.

The clustering method of MCL that we chose has been consistently reported to work better than several other methods in detecting annotated protein complexes ([@ref-32]), is more tolerant to noises in the network datasets ([@ref-44]), and is argued to be the most reliable and robust method for network clustering analysis especially when interaction networks contain many noises and missing data ([@ref-44]; [@ref-46]). Nevertheless, this clustering procedure has introduced some limitations in our analysis.

The first major limitation is that the biological meanings of many clusters generated by MCL may be limited or ambiguous. For example, GO enrichment test suggested that cluster AA1 and AA4 are involved in visual perception and eye development, but GO term related to cardiomyopathy was not enriched. Moreover, gene--gene interactions (also known as edges) in our networks are unweighted. Since MCL basically partitions genes into strongly connected groups and separates these groups based on weak-flows ([@ref-19]), MCL essentially partitions networks only based on gene connection patterns (i.e., network topology) in this study. It is known that gene expression can be used to weight gene/protein interactions and thereby improve the biological relevance of gene/protein networks ([@ref-8]; [@ref-20]; [@ref-22]; [@ref-36]; [@ref-48]). In the present study, we were not able to use gene expression data sets relevant for health disparity-related diseases---a limitation that we hope to overcome in the future.

The second major limitation is the difficulty for parameter optimization due to uneven cluster sizes. Like other clustering methods, MCL yields clusters with uneven sizes, and makes it challenging for us to optimize the inflation parameter to find a level of sensitivity that can be acceptable in all cases. Consequently, significant associations were mostly detected when clusters sizes were moderate but not when cluster sizes were too large. We mitigated this problem to some extent by trying a range of values for the inflation parameter, but an optimal 'default' setting remains a challenge.

In future studies, we plan to address these limitations of the present study by integrating functional genomics data sets, such as gene expressions, into gene networks to generate weighted interactions, and by developing step-wise clustering methods.

Conclusions
===========

In this study, gene clusters were inferred from two human gene/protein networks, HPRDNet and MultiNet, by the MCL clustering algorithm with different parameters. Each cluster was ranked using the products of FDR values based on the right-tailed Fisher's exact tests for enrichment of pathogenic or CNV-genes. Five clusters were consistently found to be enriched with both pathogenic genes and genes located in African-American or Caucasian CNVs. In cluster AA1, AA2, AA3 and AA4, gene *HSPB1* is duplicated more frequently in African Americans. In clusters CA1, gene *ATP2A1* is duplicated only in Caucasians. All gene clusters are associated with certain diseases that occur more often in one population than in the other. Although we only studied population-preferred CNVs and did not consider the roles of other genetic factors, our computational studies have generated some interesting hypotheses for further experimental studies to understand health disparities in these diseases.
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###### Results of gene mapping of SNPs and CNV coordinates
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###### Top-ranked clusters from HPRDNet and MultiNet
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###### Graph representations of cluster AA1, AA2 and AA3

Each rounded rectangle represents a gene and each gray line represents a gene--gene interaction. Black rounded rectangles represent non-pathogenic genes and orange rounded rectangles represent pathogenic genes. Genes labeled with red or blue ovals are located in African American CNVs or in Caucasian CNVs.
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